Cardiac diastolic dysfunction

Disease

4 papers2 findings

  • Animals4

Interventions

2

Empagliflozin

downin mice1

1 study
  1. Empagliflozin decreases cardiac diastolic dysfunction in mice.

    “EMPA administration effectively ameliorated metabolic disorders and cardiac diastolic dysfunction in HFD-fed mice.”

    Animalsin HFD-fed mice8 weeksmales

    Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation

    Lipids in health and diseaseSep 27, 2024

More on Empagliflozin

Epigallocatechin gallate

downin mice1

1 study
  1. Epigallocatechin gallate prevents cardiac diastolic dysfunction in mice.

    “Long-term administration of 100 or 200 mg EGCG prevented aging-related CDD”

    Animalsmixed with drinking waterheart100 or 200 mg6 monthsfemales

    The effect of long-term administration of green tea catechins on aging-related cardiac diastolic dysfunction and decline of troponin I

    Genes & diseasesApr 3, 2024

More on Epigallocatechin gallate

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 2Oct 2026: 03 in 12 months
Frontiers in Cardiovascular Medicine

Vessel lining damage linked to heart dysfunction in Chinese adults

In 503 retired adults in China, each 0.1-micrometre rise in a marker of vessel lining damage was linked to 12% higher odds of asymptomatic heart dysfunction.In 503 retired adults in China, each 0.1-micrometre rise in a marker of vessel lining damage was linked to 12% higher odds of asymptomatic heart dysfunction.

Cohort study of 503 peopleBiomarkers